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Fifteen.S.hydroxyeicosatetraenoic acid (15-S.HETE) specifically antag.
onizes the chemotactic action and glomerular synthesis of leukotriene B4
in the rat. In models of experimental glomerulonephritis, there is
temporal concordance between the shift in the glomerular cellular
infiltrate from neutrophils (PMN) to macrophages/nionocytes and the
suppression of glomei-ular leukotriene B4 (LTB4) generation. Since
macrophages are a rich source of 15-lipoxygenase (15-LO) products, we
investigated whether the principal product of arachidonate 15-lipoxy-
genation, 15-S-hydroxyeicosatetraenoic acid (15-S-HETE), was capa-
ble of antagonizing the proinflammatory actions of LTB4 in the rat.
PMN exhibited chemotaxis to LTB4 in a dose dependent manner with
an LC50 of 10—8 M. When rat neutrophils were pre-treated with
t5-S-HETE, chemotaxis to LTB4 was inhibited in a dose dependent
manner (maximal at 30 jiM 15-S-HETE) but, the same concentration did
not inhibit chemotaxis to n-formyl-l-methionyl-l-phenylalanine (FMP).
12-S-HETE (30 jiM) did not inhibit chemotaxis to LTB4. Glomeruli
from rats injected with nephrotoxic serum three hours earlier generated
increased levels of LTB4; prior exposure of such glomeruli to 15-S-
HETE totally normalized LTB4 production. The glomerular production
of 15-S-HETE and LTB4 was also determined 3 hours, 72 hours and 2
weeks after administration of nephrotoxic serum. Whereas there was an
early, short-lived, burst of LTB4 followed by a return to baseline levels,
the production of 15-S-HETE increased steadily over the two week
period and was present in amounts fivefold greater than LTB4. Thus,
these studies assign a role for locally generated I 5-LO derivatives in
arresting LTB4-promoted PMN infiltration and suppressing LTB4
synthesis. Coupled with our previous demonstration of counterregula-
tory interactions between lipoxins and cysteinyl leukotrienes, the
current studies provide further support for a generalized anti-inflamma-
tory role for l5-LO products through specific antagonism and/or inhi-
bition of leukotnene synthesis and biologic activities.
Leukotriene B4 [(5S, 12R)-dihydroxy-6, 14,-cis-8, l0,-trans-eico-
satetraenoic acid (LTB4)], a product of the 5-lipoxygenase
(5-LO) pathway of arachidonic acid metabolism, is a potent
chemoattractant whose primary target appears to be the poly-
morophonuclear leukocyte (PMN). LTB4 is the major 5-LO
product released during experimental glomerulonephritis [1].
Recent studies have suggested that in nephrotoxic serum ne-
phritis, LTB4-promoted PMN infiltration correlates strongly
with the reduction in glomerular filtration rate [2], Additionally,
early inhibition of 5-LO abrogates the late development of
proteinuria in the same model [3]. Interestingly, increased
glomerular synthesis of LTB4 is seen early in nephrotoxic
serum nephritis and subsequently falls below that of control
animals [1], suggesting that LTB4 production during inflamma-
tion is under tight regulatory control. The mechanism whereby
such regulation might occur has not been elucidated. Fifteen-
S-hydroxyeicosatetraenoic acid (15-S-HETE) is a product of
15-lipoxygenase metabolism of arachidonic acid and is pro-
duced in many tissues, including the kidney [4]. Fifteen-S-
HETE is known to have anti-inflammatory properties: Admin-
istration of l5-S-HETE has been shown to cause regression of
psoriatic lesions in humans [5] and to significantly reduce the
clinical severity of a canine arthritis model [61. Recently, it has
been shown that preincubation with 15-S-HETE can inhibit the
generation of LTB4 from stimulated human PMNs [7]. Fifteen-
S-HETE appears to be rapidly incorporated and stored in the
phosphatidyl inositol fraction of membrane lipids, and subse-
quently is released upon cellular activation to generate alternate
profiles of intracellular messengers and eicosanoids, in partic-
ular lipoxins A4 and B4 [7].
In view of these observations and previous observations
suggesting that rat PMNs may not exhibit chemotaxis to LTB4
[8—10], we undertook the present studies to answer the follow-
ing questions. First, do rat PMNs exhibit a chemotactic re-
sponse to LTB4 in a concentration dependent manner similar to
human PMNs? Secondly, dose pre-treatment of rat PMNs with
15-S-HETE results in inhibition of chemotactic movement
toward LTB4? Thirdly, does l5-S-HETE treatment inhibit the
generation of LTB4 by isolated glomeruli from rats with gb-
merular immune injury? Fourthly, is there evidence for glomer-
ular production of l5-S-HETE during glomerular immune in-
jury?
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Determination of chemoattractant activity
Rat peritoneal exudate PMNs were used as the responding
cells in the chemotaxis assay. PMN were obtained by peritoneal
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lavage four hours after a peritoneal injection of 10 ml thiogly-
colate broth culture medium without indicators (Difco Labora-
tories, Detroit, Michigan, USA). Cells were washed and sus-
pended in Dulbecco's phosphate buffered saline (PBS)
(Whittaker Bioproducts, Inc. Walkersville, Massachusetts,
USA) at a concentration of 2 x 106 viable PMN per ml.
Chemotactic assays were performed utilizing a multiwell cham-
ber as described previously [11]. Responding cells were placed
in the upper chamber and the potential chemoattractant was
placed in the lower chamber separated by a polycarbonate filter
with 3 micron pore diameters. Cell migration took place during
a 30-minute incubation period in a humidified incubator at 37°C.
After incubation, the filters were fixed and stained with Duff
Quick. The cells that migrated through the filter were counted
by oil immersion light microscopy (l000x). The chemotactic
activity was determined by counting the PMNs which migrated
toward the test chemoattractant in 10 oil immersion light micro-
scopic fields. Each individual value represents the average of
triplicate measurements. For all the experiments, the positive
control was n-formyl-l-methionyl-l-phenylalanine (FMP) (iO M)
and the negative control was PBS.
Control PMN were preincubated in PBS or 15-S-HETE for 20
minutes at 37°C in a humidified incubator. l5-S-HETE was
provided by Dr. Alan Brash (Vanderbilt University, Depart-
ment of Clinical Pharmacology) and I 2-S-HETE was purchased
from Biomol Research Laboratories, Plymouth Meeting, Penn-
sylvania, USA. Fifteen-S-HETE and 12-S-HETE each were
prepared as stock solutions in absolute ethanol and were added
to the appropriate volume of cell suspension to achieve the
desired concentration. In each case, the final ethanol concen-
tration to which cells were exposed was not more than 1%.
Eicosanoid purity and quantity was checked by ultraviolet
spectroscopy. Pretreatment with 15-S-HETE, l2-S-HETE, and
1% ethanol did not alter neutrophil viability which was mea-
sured as 95% by trypan blue vital dye exclusion.
Determination of LTB4 production by isolated glomeruli
Glomeruli were isolated from 200 g Munich Wistar rats three
hours after intravenous injection of either nephrotoxic serum
(N = 3) prepared as previously described [12], or with normal
rabbit serum (N = 3) (control). Glomerular isolation was
achieved by a modification of the differential sieving technique,
aimed at optimizing glomerular viability. In brief, the removed
kidneys were immediately placed in a physiologic buffer (Buffer
A) consisting of 105 mi NaCI, 24 mi NaHCO3, 5 ms KCI, 2
mM NaHPO, 1 mi MgSO4, 1.5 mM CaC12, 5 mM glucose, 1
mM L-alanine, 10 mi HEPES, and 0.2% BSA at pH 7.4, which
was prebubbled with 95% 02/5% CO2 for 30 minutes. The
cortical tissue was then minced at 4°C and transferred to
another beaker containing a solution of 0.3 mg/mI collagenase
Sigma, Type I, (Sigma Chemical, St. Louis, Missouri, USA) in
Buffer A, and bubbled in this solution with 95% 02/5% CO2 for
45 minutes at 37°C. Differential sieving was then carried out by
passing cortical tissue sequentially through 150 and 75 micron
sieves, with warming and gentle centrifugation. The glomerular
preparation that was obtained was >95% pure. The isolated
glomeruli from single animals were then pre-incubated with
either buffer A (control) or l5-S-HETE for 20 minutes at 37°C.
Thereafter, the calcium ionophore A23 187 (2 M) was added to
each preparation for 45 minutes. In a similar manner glomeruli
were isolated from single animals in order to determine the time
course of LTB4 production. Glomeruli were isolated as de-
scribed above from rats that had been previously injected with
either normal rabbit serum (control; N = 3) or nephrotoxic
serum [12] three hours (N 3), 72 hours (N = 3) and two weeks
(N = 3) earlier. The isolated glomeruli were then exposed to the
calcium ionophore A23 187 (2 M) for 45 minutes. The reaction
was stopped by the addition of three volumes of absolute
ethanol. Subsequently the extraction and quantitation of LTB4
was performed by high-pressure liquid chromatography and
radioimmunoassay (RIA) as described [1], and expressed as
picograms per mg of glomerular protein. For the LTB4 RIA the
coefficient of correlation was —0.9862 for the standard curve
points 25, 50, and 100 picograms; and —0.9457 for the standard
curve points 100, 200, and 400 picograms. The sensitivity of the
standard curve was 12.5 picograms. The interassay coefficient
of variation was 8.6% at 30 picograms per milliliter. The
intra-assay coefficient of variation was 3.8% at 28 picograms per
milliliter.
Determination of 15-S-HETE production by isolated glomeruli
Glomeruli were isolated as described above from rats that
had been previously injected with either normal rabbit serum
(control; N 3) or nephrotoxic serum [12] three hours (N = 3),
72 hours (N = 3) and two weeks (N 3) earlier. The isolated
glomeruli were then exposed to the calcium ionophore A23 187
(2 M) for 45 minutes. The reaction was stopped by the addition
of three volumes of ethanol. Subsequently the extraction and
quantitation of lS-S-HETE was performed by high-pressure
liquid chromatography and RIA. For the 15-S-HETE RIA the
coefficient of correlation was —0.9577 for standard curve points
16, 40 and 100 picograms; and —0.9497 for standard curve
points 100, 250 and 625 picograms. The sensitivity of the
standard curve was 16 picograms. The interassay coefficient of
variation was 15.4% at 73 picograms per milliliter. The intra-
assay coefficient of variation was 7.2% at 100 picograms per
milliliter.
Statistics
One way analysis of variance was performed between
groups; P < 0.05 was considered to be significant.
Results
Rat neutrophils exhibited a chemotactic response to LTB4 in
a concentration dependent manner (Fig. 1). The peak response
was observed at a concentration of l06 M LTB4 while the half
maximal response was observed at a concentration of i0 M
(LC50). These findings are consistent with the responses ob-
served with human neutrophils [13].
Pre-treatment of neutrophils with lS-S-HETE (30 M) for 20
minutes resulted in complete inhibition of chemotaxis to LTB4
(Fig. 1). These results are representative of three separate
experiments. In each of these experiments, migration to PBS,
which served as a negative control, was negligible. The effect of
pre-treatment with l5-S-HETE on chemotaxis to LTB4 was
titratable with no effect observed with pre-treatment with 10
LM, a significant intermediate effect with 15 M, and a maximal
effect with 30 M of l5-S-HETE (Fig. 2).
Molar concentration of LTB4
Fig. 1. The chemotactic activity of LTB4. The chemotactic activity is
expressed as the mean number of neutrophils per 10 oil immersion light
microscopic fields (OIF) (N = 3). The molar concentration of LTB4 is
shown on the horizontal axis. Symbols are: (•) PMNs that were
pre-treated with PBS (control); (0) PMNs that were pre-treated with
15-S-HETE (30 sM) for 15 minutes.
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Fig. 2. The effect of pre-treatment of PMNs with 15-S-HETE on
chemotactic response to LTB4. The data is expressed as percent
inhibition of migration as compared to control PMNs which were not
pre-treated. The micromolar concentrations of 15-S-HETE are shown
on the horizontal axis. < < 0.005 versus control (one way
ANOVA).
To determine the specificity of this effect to LTB4, we
examined the effect of pre-treatment with 15-S-HETE on neu-
trophil migration to FMP. Figure 3 demonstrates the dose
response curve of chemotaxis to FMP by control neutrophils
and neutrophils that were pre-incubated with 15-S-HETE.
There was no significant difference between the two.
To determine if the inhibition of LTB4-evoked chemotaxis
was specific for 15-S-HETE, neutrophils were pretreated with
12-S-HETE at the same concentration (30 JLM) and the above
experiments repeated. Twelve-S-HETE had no effect on LTB4-
promoted chemotaxis (Fig. 4). In addition, pretreatment with
vehicle (1% ethanol) had no effect on neutrophil migration (data
not shown).
In view of the fact that 15-S-HETE had been shown to
decrease production of LTB4 by neutrophils 117], we examined
the effect of 15-S-HETE on LTB4 production by isolated
40
glomeruli. Figure 5 demonstrates the production of LTB4
measured from isolated glomeruli obtained from rats three
hours after injection of nephrotoxic serum, and stimulated with
2ILM calcium ionophore A23 187. The data is represented as a
percent of the total LTB4 measured from control (rabbit serum
treated) glomeruli that were stimulated in an identical manner
[total LTB4 measured, mean values (N = 3): control, 203.5
pg/mg protein, nephrotoxic serum, 454.8 pg/mg protein, neph-
rotoxic serum followed by pre-incubation with 15-S-HETE,
219.0 pg/mg protein]. Clearly, nephrotoxic serum nephritis
resulted in increased production of LTB4 at three hours.
Pre-incubation of glomeruli with 15-S-HETE for twenty min-
utes resulted in marked abrogation of LTB4 production (P <
0.005). Finally, to explore the physiologic relevance of 15-S-
HETE during experimental glomerulonephritis we determined
the production of l5-S-HETE by glomeruli isolated from rats
three hours, 72 hours and two weeks after administration of
nephrotoxic serum and stimulated with 2 LM calcium ionophore
A23187. As shown in Figure 6, the production of LTB4 by
isolated glomeruli followed the pattern that has been described
previously [1, 14, 15]: there was an early peak in the first three
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Fig. 3. Effect of pre-treatment of PMNs with 15-S-HETE on PMN
chemotactic response to FMP. No significant effects are demonstrated.
Chemotactic activity is defined in Figure I.
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Fig. 4. The effect of pre-treatinent of PMNs with 12-S-HETE or
15-S-HETE. PMNs were pre-incubated with either PBS (control),
12-S-HETE (30 /sM) or 15-S-HETE (30 p.M). Chemotactic activity is
defined in Figure 1. (N 3). p < 0.005 versus control (one way
ANOVA).
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Fig. 5. Production of LTB4 by isolated glomeruli. The data represent
production of LTB4 by isolated glomeruli obtained from rats three
hours after injection of nephrotoxic serum, pre-treated with either PBS
or 30 LM 15-S-HETE and stimulated with 2 LM calcium ionophore
A23 187. The data are expressed as an increase in LTB4 production over
that measured from control (rabbit serum treated) glomeruli that were
stimulated in an identical manner (N = 3). < 0.02.
hours following injury and a subsequent return to baseline
levels. The production of 15-S-HETE, however, was fivefold
greater than LTB4 production and increased steadily over the
two week period following initial injury.
Discussion
Glomerular synthesis of LTB4 is enhanced markedly early in
the course of several forms of glomerular immune injury,
including those characterized by PMN infiltration, such as early
nephrotoxic serum (NTS) nephritis [1, 14—16] and anti-thymo-
cyte (a-Thyl.1 Ag)-antibody nephritis [171, or in the absence of
PMN involvement, such as in cationic bovine gamma globulin
(CBGG)-induced glomerular injury and passive Heymann ne-
phritis (PHN) [15, 17, 18]. In these studies, LTB4 was measured
in the supernates of isolated glomeruli either by high-pressure
liquid chromatography and radioimmunoas say [1, 15—18] or by
gas chromatography and mass spectroscopy [14], The cellular
origin of augmented LTB4 synthesis in injured glomeruli re-
mains undefined. Lianos [I] and Schreiner, Rovin and Lefko-
with [161 suggest non-leukocyte source in NTS nephritis, but
implicate PMNs in the enhanced LTB4 generation of PHN and
a-Thy 1 .1 Ag-induced nephritides [17]. While there is discrep-
ancy as to its cellular origin during glomerular injury, all studies
concur as to the transient nature of LTB4 release (LTB4 levels
are undetectable beyond the first 24 to 48 hours of injury [1,
14—18]). In NTS-induced injury, suppression of LTB4 synthesis
accompanies the shift in the glomerular infiltrate from one
comprised mainly of PMN s to a macrophage/monocyte infil-
trate, localized in the mesangium [1, 14—161. The temporal
concordance between the disappearance of PMNs and the
suppression of LTB4 generation brings into focus the potential
role of locally generated anti-chemotactic mediators in arresting
LTB4-promoted PMN infiltration and possibly suppressing
LTB4 synthesis. Since macrophages are a rich source of 15-LO
products [4, 19—21], we investigated whether the principal
product of arachidonate 15-lipoxygenation, 15-S-HETE, was
capable of exerting counterregulatory effects to antagonize the
.
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Fig. 6. Production of 15-S-HETE (A) and LTB4 (•) by isolated gb-
meruli. The data represent production of 15-S-HETE and LTB4 by
isolated glomeruli obtained from rats at 0 hour, 3 hours, 72 hours and
two weeks after injection of nephrotoxic serum and stimulated with 2
Mcalcium ionophore A23 187. (N = 3). *p < 0.05 versus 72 hours (one
way ANOVA).
proinflammatory actions of LTB4 in the rat. This became
particularly relevant in view of the recent demonstration of the
modulation of PMN activation by their prior incubation with
15-S-HETE and of the anti-chemotactic properties of the 15-LO
product, lipoxin A4 [22].
At the outset, it was essential to demonstrate that rat PMNs
do indeed respond to the chemotactic activity of LTB4, in view
of past studies suggesting lack of activity for LTB4 in this
species [8—101. As demonstrated in Figure 1, rat neutrophils
exhibit chemotaxis to LTB4 in a dose dependent manner similar
to the response seen with human neutrophils [13]. The tapering
of the response curve at supraphysiologic concentrations of
agonist is also described for the response of human PMNs, and
the peak response concentration and the LC5O are highly
consistent with those described previously for human leuko-
cytes [13].
When rat neutrophils were pretreated with 15-S-HETE,
chemotaxis to LTB4 was inhibited with the peak response
observed at 30 M 15-S-HETE (Fig. 1). The inhibitory effect of
15-S-HETE displayed several characteristics which suggest
strongly that it is biologically relevant: (i.) The degree of
inhibition of LTB4-provoked chemotaxis was dependent on the
concentration of l5-S-HETE (Fig. 2). (ii.) The inhibition of
chemotaxis by 15-S-HETE was not due to a generalized toxic
effect on PMN function, since the response of these cells to the
chemotactic action of FMP, even at the highest concentration
of 15-S-HETE tested, was still robust and displayed the ex-
pected dose-dependence (Fig. 3). Further, we did not observe a
decrement in trypan blue dye exclusion with pre-treatment with
15-S-HETE. (iii.) The inhibitory action of 15-S-HETE appears
to be specific to this eicosanoid, since a structurally similar
compound, 12-S-HETE, was without effect on LTB4-induced
chemotaxis (Fig. 4). Thus, both LTB4 and 15-S-HETE display
reciprocal specificity in their biological interactions (Figs. 3 and
4).
The mechanism(s) underlying the capacity of 15-S-HETE to
specifically antagonize the leukoattractant actions of LTB4
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remained incompletely defined. The recent evidence by Brez-
inski and Serhan [71, however, suggests that the specific incor-
poration of 15-S-HETE into the phosphotidylinositol fraction of
cell membrane lipids results in the generation of a 15-S-HETE
substituted diacyiglycerol (DAG) upon cellular stimulation by
agonists which activate phospholipase C (PLC). The generation
of this "altered second messenger" would be expected to
markedly attenuate cellular responses. Interestingly, the inter-
actions of LTB4 with PMN receptors has been convincingly
linked to the activation of PLC and secondary generation of
DAG and inositol trisphosphate [231. Other potential mecha-
nisms underlying the modulation of LTB4 actions by 15-S-
HETE include possible effects on PMN LTB4 receptor binding
affinity or number, or other interruptions of LTB4 receptor-
coupled intracellular signalling pathways. These mechanisms
are under investigation.
Additionally, we examined whether the anti-inflammatory
action of 15-S-HETE was restricted to the antagonism of
LTB4-evoked PMN attraction, or extended to the regulation of
LTB4 biosynthesis. To begin an investigation of this question,
we tested the capacity of 15-S-HETE to suppress the synthesis
of LTB4 in glomeruli isolated from acutely inflamed rat kidneys
under the influence of nephrotoxic serum. Since these glomer-
uli, isolated from the rat three hours after the injection of NTS,
are already characterized by a marked PMN infiltrate [16], any
effect of 15-S-HETE on LTB4 synthesis would not be a result of
its anti-chemotactic action described above. Glomeruli isolated
from NTS-treated animals displayed a 225% increase in LTB4
generation, as compared to rabbit serum-injected controls (Fig.
5, left bar). This finding is in concordance with those reported
previously by numerous other investigators in this model of
injury [1, 14, 15]. In dramatic contrast, however, pre-incubation
of similarly isolated glomeruli with 15-5-HETE totally abol-
ished the augmented synthesis of LTB4 by these inflamed
glomeruli. Since LTB4 generation is itself a consequence
of leukocyte activation [24], the mechanism underlying the
inhibition of LTB4 synthesis by l5-S-HETE may well be similar
to those described above for its abrogation of LTB4-mediated
chemotactic responses. In fact, generation of LTB4 from
human neutrophils following activation by the calcium iono-
phore A23 187 is markedly attenuated by prior incubation with
15-5-HETE [71. Finally, we determined the time course of
15-S-HETE production by isolated glomeruli in rats with neph-
rotoxic serum nephritis. Interestingly, the 15-5-HETE is pro-
duced in relative abundance as compared to LTB4, and in
addition, the production of 15-S-HETE increases progressively
over the two week period while the levels of LTB4 fall
dramatically. The relatively high glonierular generation of 15-
S-HETE correlates well with the higher levels required in vitro
to achieve the observed antagonistic effects of l5-S-HETE on
the actions of LTB4 (Fig. 2). The cellular source of 15-S-HETE
produced by isolated glomeruli could not be determined from
these experiments and may very well be the macrophage
infiltrate as opposed to the endogenous glomerular cells. In-
deed, the enhanced production of l5-S-HETE is greatest be-
yond 72 hours after the lesion is induced, and as such correlates
well with the predominance of macrophages in the lesion at that
time [16].
In nephrotoxic serum nephritis, suppression of LTB4 synthe-
sis accompanies the shift in the glomerular infiltrate from one
composed mainly of neutrophils to a macrophage/monocyte
infiltrate, localized in the mesangium [161. Since the macro-
phage lesion which follows is a potentially major source of
15-5-HETE [4, 19—21], it is tempting to speculate that 15-S-
HETE released locally from macrophages is, in part, responsi-
ble for the suppression of LTB4 generation, and further con-
tributes to the suppression of neutrophil infiltration by actively
inhibiting LTB4-mediated chemotaxis.
In summary, we have demonstrated that rat PMNs are a
target for LTB4-promoted chemotaxis, validating the use of rat
models of inflammation to study the roles of LTB4 in glomer-
ular injury. Further, these studies provide evidence that the two
lipoxygenase products, LTB4 and 15-5-HETE, display recipro-
cally specific interactions in vitro, whereby 15-S-HETE antag-
onizes the chemotactic activity of LTB4 and appears to sup-
press its biosynthesis in inflamed glomeruli. Coupled with our
previous demonstration of counterregulatory interactions be-
tween lipoxins and cysteinyl leukotrienes by competition for
common binding sites [25], the current studies provide further
support for a generalized anti-inflammatory role for 15-lipoxy-
genase products through specific antagonism and/or inhibition
of leukotriene synthesis and biologic activities.
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